SELENOT and serum lipopolysaccharide activity: In conclusion, SELENOT, which is upregulated by LPS in EC expressing APEX1(1-20), seems to be an important mediator of the protective effects of APEX1(1-20) and could thus be of interest as an adjuvant therapeutic agent in endotoxemia.